561 ECCLES AVENUE, SOUTH SAN FRANCISCO, CA
Market cap: $954.9M (2/09/2026)
Price: $57.74
Enters Agreement to Acquire RAPT Therapeutics
Investor Presentation
Dr. William Ho Departure - Chief Medical Officer to Leave RAPT Therapeutics
Reports Third Quarter 2025 Financial Results and Recent Highlights
RAPT Therapeutics Announces Underwritten Public Offering of 8.33M Shares
Earnings Release
Q3
Q2
Q1
FY 2024
FY 2023
Solicitation/Recommendation Statement
Tender Offer Statement by Third Party
Tender Offer Statement by Issuer
Schedule 14D-9C Solicitation/Recommendation Statement Communication
Prospectus filed pursuant to Rule 424(b)(5)
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
Amended Schedule 13G - Ownership Report